已收盘 05-22 16:00:00 美东时间
+0.020
+0.07%
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从9美元升至11美元;康托·菲茨杰拉德:维持Artiva Biotherapeutics"超配"评级,目标价从10美元升至40美元
05-12 12:36
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从15美元升至35美元;韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从36美元升至37美元
05-11 15:43
Wells Fargo analyst Joseph O'Dea maintains Centuri Holdings (NYSE:CTRI) with a Overweight and raises the price target from $32 to $37.
05-08 21:52
Centuri Holdings shares are trading lower. The company reported Q1 financial re...
05-08 02:49
华盛资讯5月7日讯,Centuri Holdings, Inc.公布2026财年Q1业绩,公司Q1营收7.23亿美元,同比增长31.5%,归母净利润亏损0.10亿美元,同比亏损缩窄46.9%。
05-07 06:15
华盛资讯5月7日讯,Centuri Holdings, Inc.公布2026财年Q1业绩,公司Q1营收7.23亿美元,同比增长31.5%,归母净利润亏损0.10亿美元,同比亏损缩窄46.9%。
05-07 06:02
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Centuri Holdings (NYSE:CTRI) affirms FY2026 sales outlook from $3.150 billion-$3.450 billion to $3.150 billion-$3.450 billion vs $3.355 billion estimate.
05-07 04:19
Centuri Holdings (NYSE:CTRI) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.07) by 71.43 percent. This is a 83.33 percent increase over losses of $(0.12) per share from
05-07 04:19
Shares of companies in the broader industrial sector are trading higher as FY26...
05-01 02:06